From cell to multi-crypt: Agent-based models of the human colon suggests novel processes of field cancerisation by Ingham-Dempster, T.A. et al.
This is a repository copy of From cell to multi-crypt: Agent-based models of the human 
colon suggests novel processes of field cancerisation.




Ingham-Dempster, T.A., Rosser, R., Corfe, B.M. et al. (1 more author) (2020) From cell to 
multi-crypt: Agent-based models of the human colon suggests novel processes of field 
cancerisation. Journal of Computational Science. 101066. ISSN 1877-7503 
https://doi.org/10.1016/j.jocs.2019.101066





This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
From Cell to Multi-crypt: Agent-based Models of the Human Colon 
Suggests Novel Processes of Field Cancerisation  
Timothy A. Ingham-Dempster1,2,3, Ria Rosser2, Bernard M. Corfe,1,2, and Dawn C. 
Walker*,1,3 
 
1INSIGNEO Institute, University of Sheffield, The Pam Liversidge Building, Mappin 
Street, Sheffield, S1 3JD, UK 
2Molecular Gastroenterology Research Group, Department of Oncology and Metabolism, 
The Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK 
3Department of Computer Science, University of Sheffield, Regent Court, 211 Portobello, 
Sheffield, S1 4DP, UK 








Colorectal cancer (CRC) is a major cause of cancer mortality.  It is known that loss of APC 
gene function through mutation is followed by the expansion of a field of mutated tissue, but 
the mechanisms behind this expansion are poorly understood.  
This study aimed to examine the processes involved in field expansion using two agent-
based computational models: a cell-scale model allowing mapping of Apc-mutated cell 
expansion in small multcrypt arrays, and a tissue-scale model allowing simulation of the 
entire colon over oncologically relevant timescales.  
The cell scale model predicts that mutated cells spread through the flat mucosa of the 
simulated tissue without invading neighbouring crypts - a process not previously 
hypothesised in the literature. The crypt-scale model’s predictions of field sizes correspond 
to those estimated in the literature from in vivo studies. Our dual-scale modelling approach 
renders the spatial and temporal scales at which field cancerisation processes occur in vivo 
accessible to exploration by simulation for the first time. 
 
Highlights 
• We present novel multiple-scale agent-based models of the colon, where agents are 
used to represent both individual cells and entire crypts 
• This approach allows us to simulate cancerous field spread in clinically relevant 
tissue areas consisting of up to 40000 crypts 
• Our model simulations suggest a process of mutated cells spreading through the flat 
mucosa only, without invading neighbouring crypts. 





Agent-based modelling, colorectal cancer, multi-scale modelling, simulation 
 
Introduction 
Field Cancerisation in the human colon 
The human colon consists of a monolayer epithelium punctuated by test-tube shaped 
invaginations known as the crypts of Lieberkühn.  These crypts act as cell factories to supply 
the large number of cells required to maintain an epithelium in the hostile environment of the 
colon, necessitating a constant process of division and differentiation within the colon.  
Disruption of these processes is implicated in the formation of colorectal cancers (CRC) [1]. 
Changes to the Adenomatous Polyposis Coli (APC) gene, and expression of its associated 
protein, are strongly linked to the initial stages of adenoma formation [2].  A number of 
changes to cell behaviour are associated with mutation of this gene including: reduction in 
cell rigidity, a decrease in the quiescent time before cell cycle re-entry, and increased 
resistance to anoikis [3]. 
There is strong evidence that individual crypts are monoclonal in nature; this has been 
shown through studies on chimeric mice [2] and in an XO/XY mosaic human [4].  The 
mechanism behind this monoclonal conversion has been elucidated and examined via 
computational modelling techniques [5, 6]. By contrast, in vivo studies [2, 4] have suggested 
that adenomas are almost exclusively polyclonal in nature, although alternate explanations 
have been proposed [4]. This, combined with the monoclonality of individual crypts, suggests 
that multiple crypts are involved in the formation of adenomas.  These processes are difficult 
to observe in vivo, as they occur over spatial and temporal scales which make them 
inaccessible to biological techniques, and hence are poorly understood.  
A number of studies [7, 8] have suggested that fields of tissue exist around adenomas which 
are endoscopically normal but exhibit alterations at lower scales and have increased risk of 
further adenoma formation [9] this falls within the concept of field cancerisation [10]. There 
are two principal competing hypotheses in the literature as to the mechanism behind field 
spread.  The top-down hypothesis [11] proposes that proliferative advantages caused by the 
pre-cancerous mutations present in cells from that original crypt invade neighbouring healthy 
crypts.  Once this invasion has occurred the proliferative advantage of the mutated cells 
allows them to take over the neighbouring crypt by subverting the process of monoclonal 
conversion, thereon progressively expanding through the local mucosa. 
The bottom up hypothesis [12] is centred around the process of crypt fission.  This process 
occurs in healthy tissue as a normal part of epithelial homeostasis.  Fission is accelerated by 
an order of magnitude in tissue of patients with a number of diseases related to CRC [13] so 
it is hypothesised that crypts with pre-cancerous mutations have an elevated rate of crypt 
fission.  This in turn causes mutated crypts to clone themselves at a higher rate than the 
homeostatic replacement rate, leading to an expanding patch of mutated tissue.  This is 
currently the most strongly supported of the two hypotheses following both experimental and 
single crypt-scale computational studies [14, 15]. 
To date, the direct influence of multiple aspects of cellular phenotype on adenoma formation 
has not been investigated by computational simulation, possibly due to data scarcity, and 
also the computational demands of modelling across multiple scales. 
 
Computational Modelling of the Colon Crypt 
The colon crypt has been the focus of numerous computational and mathematical modelling 
studies, with varying scales of resolution. Relatively computationally undemanding 
approaches include compartment-based models, which represent sub-populations of stem, 
transit amplifying and differentiated cells [16] and in the case of the colon,  the effects of 
asymmetric cell division [17] and the enteroendocrine cell population [18]. These concepts 
were extended to include spatial localisation of these sub-populations in continuum models 
[19] or applied to model the effects of biomechanical stress  [15]. Other approaches based 
on spatial discretisation include Cellular Automata (CA) models, which have been used in 
order to study intra-tumour heterogeneity on the scale of the whole colon [20]. 
Given the importance of cellular phenotype in determining crypt behaviour, more recent work 
has focussed on the representation of cells as individual entities capable of explicit 
interactions. The Cellular-Potts method uses the concept of minimisation of an energy 
function in order to define cell contacts. This approach has been used to study the emergent 
effects of differential Ephrin-B receptor density along the crypt axis [21], but have the 
drawback of being computationally expensive, with a potentially non-intuitive reduction of 
complex cell behaviours to physics driven concepts. Lattice-based crypt models [22] 
consider the behaviour of individual cells, but confine their movement to occupying fixed grid 
sites, meaning that explicit consideration of cell-cell and cell microenvironment interaction 
forces are not possible.   
Agent based models (ABMs) capture the dynamic behaviour of complex systems using 
software agents, with each agent being an autonomous entity directly analogous to real 
world entities (e.g. individual biological cells in a tissue). Each software agent makes 
decisions based on its internal state and the local environment but is not governed by an 
overarching control mechanism.  By combining many such agents with a suitable 
environment, complex behaviours arise which reflect the behaviour of the system being 
modelled.  The “cell as agent” approach fits well, as biological cells act as fundamental units 
or entities which make decisions based on a combination of their internal state and local 
environment, with complex behaviours emerging via local coordination. However, agents can 
also be applied at varying levels of hierarchy in order to capture the outcome of emergent 
behaviour. In the biological world, agents have also been used to represent molecules within 
cells [23] and hierarchical agents applied from the level of cells, through tissues and organ to 
develop a systemic model of inflammation [24]. In another field of application, the context of 
economics, hierarchical agents have been used to model households, firms and banks of 
various sizes [25]. 
In the context of the colon crypt, the first lattice-free cellular-scale ABM used the concept of 
cell centres as points connected by springs to represent intercellular forces [26] – an 
approach adopted by many subsequent crypt models, including the models presented here. 
More recent models have been applied to elucidate the process behind crypt monoclonality 
[5], the effects of known pre-cancerous mutations on monoclonal conversion [6],cell 
migration in the crypt [27] and anoikis [28]. 
Our previous study [29] considered the impact on the crypt mouth of known changes to the 
behaviour of cells within the crypt arising from pre-cancerous mutations.  One of the 
predictions of this study was that the mutated cells have a competitive advantage at the 
crypt mouth and possibly on the flat mucosa which allowed them rapidly to dominate this 
region.  As the crypt mouth is the junction between crypts we hypothesise that this behaviour 
may have bearing on the processes underlying field cancerisation. 
The current study has three main aims: 
• To examine the consequences of the behaviours seen in the previous study 
[29], particularly as related to field spread; 
• To assess whether the predictions arising from both the previous and the 
current study are consistent with in vivo findings; 
• To study the effect of behaviours identified at multi-crypt level when modelled 
over clinically-observable spatial scales and a timescale of multiple decades 
The process of field cancerisation extends beyond the individual crypt, and hence cannot be 
captured by a cellular-scale single crypt model. In order to achieve these aims, we initially 
extended our cellular scale model to represent multiple crypts in order to simulate the 
characteristics of spread of mutated cells at a fine scale of resolution. We then developed 
our macro-scale model (where agents represent individual crypts) and calibrated this against 
the cell scale model, with encoded mechanisms reflecting the behaviours predicted by the 
latter. Finally, we introduce the process of crypt fission in order to generate initial predictions 
relating to field spread at the macroscopic scale.    
Materials and methods 
Cell level model 
An Agent-Based model (ABM), where one computational agent represents one biological 
cell, [28] was used to investigate phenomena related to field spread in a number of 
simulation experiments.  The existing model was extended from a single crypt into a model 
of a patch of colonic tissue covering multiple crypts, patches of 5x5, 9x9, and 15x15 crypts 
have been simulated. A 5x5 simulation is visualised in Fig 1A. 
Fig 1. 
As previously described [29], this lower-scale model incorporates rules representing some of 
the known effects of Apc loss on the virtual cells.  Specifically, reduced cell stiffness and 
reduced stem cell quiescent time are modelled by modifying the parameters which control 
those attributes.  Resistance to anoikis is modelled by increasing the strength of a cell’s 
attachment to the basement membrane. 
For the current study, an area of flat mucosa was added to the model connecting multiple 
crypts together and rules were created to allow cells to migrate between crypts based on 
proximity (Box 1).  The extent of the spread of mutated cells throughout a simulation was 




A range of model sizes (in terms of total crypt number) with both reflective (agents impacting 
the boundary are pushed back with a restoring force) and absorbing (agents reaching the 
boundary are effectively removed from the model) boundary conditions, were tested to 
determine any variation in model predictions of field spread according to these factors and 
Box 1 
For each cell 
 For each crypt 
  If(distanceTo crypt < distanceToCurrentCrypt) 
   make crypt cell’s parent crypt 
 
hence the least computationally intensive model that could justifiably be used for a sensitivity 
analysis. This process is described in Supplementary Material 1. 
Crypt-Level model 
The second model was created specifically for this study and represents individual crypts as 
agents.  This allows areas of millions of crypts to be simulated over multi-year timescales at 
the cost of granularity of results, a simulation of 40,000 crypts is visualised in Fig 1B.  The 
rules governing the behaviour of crypts are as follows: 
Growth - each wildtype crypt has a life cycle [30] which consists of growing or shrinking at a 
constant rate until a target length is met.  When this length is achieved the next target length 
is drawn from a normal distribution. Typical behaviour of a crypt within a simulation is shown 
in Fig 1C. 
Fission - if a crypt is longer than a global length threshold, then the crypt divides into two 
crypts.  This threshold and the normal distribution from which target lengths are drawn were 
calibrated to create a fission rate which matches known biological data [1]. 
Extinction - if a crypt shrinks below a certain length threshold the crypt will become extinct 
and be removed from the simulation.  This rule is phenomenologically motivated, in that 
whilst such extinctions have not been reported in the literature, it is not obvious how they 
could be observed. The motivation for the extinction rule is a baseline assumption of global 
crypt homeostasis: without it, the known rate of crypt fission predicts a full order of 
magnitude increase in crypt density over a four decade span and no such increase has been 
observed.  These three rules are summarised in Box 2 and Fig 1C. 
 
If a crypt is designated as mutated, its lifecycle will change to one of constant growth and 
division cycles (Box 2).  This calibrated behaviour produces a crypt division rate for mutated 
crypts which is approximately 20x higher than for wildtype crypts which matches known 
biological data [1]. 
Crypts can move over the two-dimensional surface and use a damped spring model to 
prevent crypts from overlapping.  This model is similar to the one used to resolve cell-cell 
overlaps in the cell scale model and obeys Eq1: 
v = ((r1 + r2 - |p1 – p2|) * ((p1 – p2) / |p1 – p2|) * k) if |p1 – p2| < r1 + r2   (1) 
 
Where v is the velocity of the crypt for this timestep, p1 and p2 are the positions of the two 
cells and r1 and r2 are their radii (Fig 1D). 
Crypts can be defined as either wild-type or mutated (i.e. a cell within the crypt has at some 
point in the past mutated and come to colonise the crypt through monoclonal conversion [5].  
When a crypt is designated as mutated, a variable representing the percentage of mutated 
cells within the flat mucosa above the crypt is incremented each timestep by either a fixed 
Box 2 
      For each crypt 
 If(Crypt Isn’t Mutated) 
  If(Length < target) 
   Length += growthRate 
  Else 
   Length -= growthRate 
  If(Length > divisionThreshold) 
   Divide 
  If(Length < 0) 
   Remove from Simulation 
 
Else If(Crypt Is Mutated) 
  Length += growthRate 
  If(Length > divisionThreshold) 
   Divide 
 
amount or an amount drawn from a normal distribution to represent mutated cells flowing 
into the flat mucosa from the mutated crypt below (Box3). 
 
If the flat mucosa contains more than 90% mutated cells, these cells will begin to overflow 
into the flat mucosa associated with neighbouring crypts.  This is implemented via a rule 
which, for each pair of neighbouring crypts, moves a number of mutated cells from the flat 
mucosa above the crypt with the higher mutation percentage to the flat mucosa above the 
crypt with the lower mutation percentage (Box 4). 
 
If a crypt moves beyond the simulation boundary in the y dimension a restoring force is 
applied proportional to the distance beyond the boundary that the crypt has moved.  This 
creates a fixed boundary in the y dimension to represent the ends of the colon. 
If a crypt moves beyond the simulation boundary in the x dimension it is moved to the other 
side of the simulation plane.  This forms a wraparound boundary to simulate the colon as an 
open ended cylinder (Box 5). 
 
Box 3 
For each crypt 
 If (Crypt Is Mutated) 
  Mucosal Mutation Amount += Mutated Cell Production Rate 
Box 4 
For each crypt 
 For each NeighbourCrypt 
  If (Mucosal Mutation of Either Crypt > 90%) 
Number of Cells Migrating = Difference in Mucosal 
Migration * Flow Constant 
Largest Mucosal Migration -= Number of Cells Migrating 
Smallest Mucosal Migration += Number of Cells Migrating 
Box 5 
For each crypt 
 If (Crypt.x is Beyond x Boundary) 
  Move Crypt to Opposite Side of Simulation 
 If (Crypt.y is Beyond y Boundary) 
  Apply Restoring Force 
Crypts along one side of the simulation boundary in the x dimension can interact with crypts 
on the other side to complete the wraparound conditions.  These interactions apply both to 
crypt overlap resolution forces and to the mucosal mutation spread rules. 
The cell scale model was used to conduct a number of simulation experiments relating to the 
spread of cells exhibiting Apc loss, denoted as Cell Experiment 1, 2 etc. Following a 
calibration process, the results of these simulations were then used to inform the upper scale 
model, which was used to conduct simulations representing a macroscopic section of colon, 
described below in Crypt Experiment 1.  
All cell-level model parameters are shown in Table 2 in [28]. Table 1 below contains the 
parameters used for the crypt experiments. 
Parameter Value 




Simulation time step  8 hours 
Crypt growth per time step 0.02 (arbitrary units) 
Crypt fission threshold 1  (arbitrary units) 
Crypt extinction threshold 0 (arbitrary units) 
Mean time to wildtype crypt fission 20 years 
Mean time to mutated crypt fission 2 years 
Table 1 – Parameters for crypt-as-agent simulations 
Results 
Modelling Apc loss in a multi-crypt environment predicts invasion of the flat mucosa 
by precancerous cells 
Cell Experiment 1 was a phenomenological investigation of the behaviour of mutated cells 
within a multi-crypt model.  This was initialised as an array of 5x5 crypts and run for 1000 
timesteps to reach an equilibrium state.  At this point, one cell in the centre crypt of the array 
was designated as mutated and then the simulation was observed for a further 500000 
timesteps.  Wildtype cells were coloured red and mutated cells green so that the behaviour 
of the two populations could be visualised separately. Results are shown in Fig 2A.  
Figure 2  
The primary prediction of this simulation experiment is that cells carrying a mutation causing 
APC loss spread through the flat mucosa of neighbouring crypts but do not invade the 
neighbour crypts themselves. This general prediction held for all of the 625 simulations 
performed in cell experiment 2 (a mutation rate parameter sensitivity exploration, as 
described below).  A representative visualisation of the simulation is provided in Fig 2A 
showing mucosal field spread in a typical simulation. 
There are relatively few studies yielding candidate biomarkers of Apc loss suitable for 
immunohistochemical analysis of colorectum, however an in vitro study using otherwise 
isogenic cell lines yielded keratin 18 as one such potential biomarker  [31]. Work undertaken 
previously by this group [32, 33], has also identified keratins as perturbed in macroscopically 
normal colon in the presence either of a lesion or of pathological inflammation. 
Immunohistochemical scoring protocols for keratin expression in tissue [34] were therefore 
applied to assess variability in keratin 18 expression in crypts and flat mucosa of normal 
tissue in patients with and without lesions (Fig 2B) as a proxy for alteration in Apc. This 
analysis demonstrated that there was altered expression in the flat mucosa but not the crypt 
(Fig 2B/C), agreeing with the computational predictions.   
Different mutation effects induce field cancerisation at different rates 
Following a process to determine the least computationally intensive modelling configuration 
giving acceptable results (Supplementary Material 1), Cell Experiment 2 examined the effect 
of differing parameters associated with the changes related to Apc mutation on the nature of 
the field spread between crypts.  Three parameters pertaining to individual cells designated 
as mutated cells were varied: the quiescent time of stem cells, the stiffness of the cells, and 
their resistance to anoikis.   
Parameter ranges explored for stem cell quiescent time were 10%, 25%, 50%, 75% and 
100% of wild-type value, cell stiffnesses were 10%, 25%, 75% and 100% of wild-type and 
anoikis resistance was set to 1, 2.5, 5, 7.5, and 10 on an arbitrary scale.  All possible 
combinations of these parameters were tested leading to 125 simulations, each of which 
was repeated five times to account for stochasticity for a total of 625 simulations, requiring a 
total of approximately 12,000 hours of compute time on the University of Sheffield multi-core 
research HPC cluster. 
The simulations were run, as in experiment1, for approximately one year of biological time 
and maximum mutated cell migration distance was recorded. In addition, the originating 
crypt of a mutated cell population was tracked and any cell achieving a depth of 25% or 
greater in a crypt from which it did not originate would be considered to have invaded that 
crypt.  These invasion events were logged and recorded along with the migration data to 
determine if any biologically realistic set of parameters would lead to crypt invasion. 
The mean of the spread rate for each simulation was plotted against time and three common 
predictions were identified.  The first is that there is a lag between the mutation event and 
the onset of field spread; the second is that the fields eventually reach a maximum size and 
stop spreading, and the third is the rate at which the fields reach this maximum size.  These 
three features were extracted from the data for each combination of parameter values and 
plotted to determine the contribution of each mutation effect to each feature (Fig 3A).  In all 
cases, each value of the quiescent time modification parameter was plotted as an individual 
plane of results, with the attachment force parameter plotted on the x-axis, the cell stiffness 
plotted on the y-axis and the feature being measured plotted on the z-axis. 
Figure 3 
Fig 3B shows that the quiescent time modification parameter had the largest effect on lag 
time, with lower quiescent times causing lower lag times.  Reducing cell stiffness also 
affected lag time, with stiffer cells having shorter lags; this effect was emphasised for higher 
quiescent times.  Attachment force did not appear to play a role in lag time. 
As shown in Fig 3C, quiescent time change has no effect on the overall size of the field 
generated.  Attachment force and cell stiffness both affect total field spread, increasing 
stiffness reduces the overall size of the field whereas increasing attachment force increases 
the final field size. 
Fig 3D shows the effects of the parameters under test on the rate of field spread.  The 
results can be separated by quiescent time change but the effects appear to be inconsistent.  
Attachment force and cell stiffness appear to have interrelated effects, with maximal rates of 
spread occurring at high attachment force when there is low stiffness and low attachment 
force when there is high stiffness.  Parameter sets where both attachment force and cell 
stiffness are low correspond to minimal spread rate, as do ones where both mutation effects 
are high. 
A key result is that invasion of neighbouring crypts (as opposed to their flat mucosa) was not 
seen for any physiological combination of values tested.  It was, however observed in a 
small number of combinations tested outside this biologically plausible range, specifically in 
one repeat of each of the following parameter sets: 
 Cell stiffness 175%, quiescent time 10%, anoikis resistance 1.0 
 Cell stiffness 200%, quiescent time 25%, anoikis resistance 2.5 
 Cell stiffness 200%, quiescent time 25%, anoikis resistance 1.0 
 Cell stiffness 200%, quiescent time 100%, anoikis resistance 2.5 
The biological implications of these values will be considered in the discussion section. 
The mean field spread rates obtained from the cell experiments above were then used as 
parameters in the following crypt level simulations. 
 
Calibrating the Mucosal Invasion Mechanism in the Crypt Scale Model 
In order to carry out simulations using the crypt scale model, it was first necessary to 
determine consistency in the mucosal invasion mechanism in the crypt scale model and also 
to calibrate the mutated cell production parameter.  In order to do this, mechanisms not 
present in the cell scale model - specifically the crypt fission cycle and movement - were 
disabled in the higher level model. 
An array of six by six crypts was created in both the cell scale model and the crypt scale 
model.  After reaching equilibrium, the crypt at the (2,2) position (using 0-indexing) was 
designated as mutated and the spread of mutation originating from this crypt was tracked.  In 
the crypt scale model, a crypt’s flat mucosa was considered to have been colonised when its 
mutated cells percentage reached 50%.  The distance from the mutated (2,2) crypt to each 
crypt with invaded flat mucosa was calculated and the maximum distance was recorded at 
every timestep, as a measure of the spread of mutated cells in this model. 
Five crypt scale simulations were run with different values for the number of mutated cells 
produced by the mutated crypt each iteration: 10, 20, 30, 40, and 50 cells per timestep.  The 
simulations were run for approximately one year of biological time. This required only five 
hundred timesteps for the crypt scale model, as opposed to one million for the cell scale 
simulations. Fig 4A shows a visualisation of the crypt scale model, consisting of the mutated 
central crypt with a surrounding region of invaded flat mucosa, which is consistent with the 
predictions of the cell scale model (Fig 2A). The effect of varying the number of mutated 
cells generated per timestep in the crypt model is shown in Fig 4B, along with the similar 
results from a typical simulation generated using the cell level model (error bars calculated 
on the basis of five repeat simulations are shown).  It can be seen that the mutation spread 
for the crypt scale model has the same characteristic period of rapid expansion which falls 
off over time, as is the case for the cell scale model.  Additionally, spread rate is predicted to 
vary based on the value of the cell generation parameter in the crypt scale model and good 
agreement with the predictions of the cell level model can be achieved by choosing a value 
of 30 cells per timestep. This parameter was used in subsequent simulations of macroscopic 
colon tissue described below. 
Figure 4 
The crypt level model predicts a field of mutated crypts surrounded by a larger field of 
mutated mucosa 
Crypt Experiment 1 was run with the crypt scale model, with crypt fission and movement 
rules enabled, to examine the spread of mutated cells and crypts over biologically relevant 
scales.  The model was initialised with an array of two hundred crypts in each dimension, 
giving a total of forty thousand crypts, or approximately 1% of a human colon [1]. The 
simulation was run for ten thousand timesteps to represent the dynamic state of a colon in 
an individual of twenty years, at which point a single crypt near the centre of the simulation 
was mutated.  The simulation was then run for a further two decades of biological time and 
the spread of both mucosal invasion and mutated crypts was measured.  These data were 
recorded every ten timesteps and then plotted against time to characterise the predicted 
spread.  Five repeat simulations were run to account for stochasticity in the crypt cycle. 
This experiment predicted a growing field of mutated crypts which displaces the wild-type 
crypts of the healthy tissue as it grows, as shown in Fig 5A.  The expansion of this field 
accelerates over time in an exponential manner.  The experiment also predicted a larger 
field surrounding the mutated crypts, which consisted of wild-type crypts with mutated flat 
mucosa.  This field initially grows faster than the field of mutated crypts and creates a fringe 
around the fully mutated field.  The expansion of the flat mucosal field is also exponential, 
but with a slower growth rate than the field of mutated crypts, the result being that the fringe 
of invaded flat mucosa becomes thinner as its diameter increases (Fig 5B).  The mean size 
of a field at the end of the simulations was 230 crypts in diameter, which corresponds to 
approximately 41,000 crypts in total. 
Discussion 
We have demonstrated how a split scale modelling approach can be used to explore 
mechanisms of field spread of Apc mutated cells in the colon. The first part of this study 
investigated the behaviour of APC loss cells in a multi-crypt environment to examine the 
hypothesis that the competitive advantage conferred by APC loss at the crypt mouth would 
lead to invasion of neighbouring crypts.  Such invasion has been hypothesised in the 
literature, with arguments being made both for [11] and against [12] this mechanism, 
however the in-vivo evidence is ambiguous and no modelling studies which address this 
issue have been previously published. 
Our cell scale simulation experiments focussed on predicting emergent behaviour resulting 
from individual cells exhibiting various phenotypic characteristics of Apc loss, interacting with 
normal cells in the crypt mouth and specifically, whether transformed cells could migrate 
outside their crypt of origin, leading to wider tissue invasion. Cell Experiment 1 predicted that 
there was no top-down invasion of crypts but that mutated cells did invade the flat mucosa 
above and surrounding neighbouring crypts.  This method of field spread does not appear to 
have been suggested before in the literature and may be a novel process in the 
understanding of field cancerisation.  A study of the literature led us to assess variation in in 
keratin 18 (a candidate marker for APC loss,  [31], in crypts and flat mucosa. Availability of 
formally recognised biomarkers of Apc loss is a limitation not only of this study, but in the 
wider literature. Based on our data, the differences in keratin 18 perturbation in patients with 
an adenoma compared to those without, is consistent with the prediction of APC loss cells in 
the flat mucosa surrounding adenomas but not in the crypts at the same location  This 
similarity in the predicted flat mucosal localisation suggests that this mechanism may indeed 
dominate in vivo and follow-up work should be done to determine if this is the case and to 
what extent these cells could participate in carcinogenic processes. 
Cell Experiment 2 sought to quantify the relationship between the three phenotypic effects of 
APC loss represented in the model and the characteristic properties of field spread.  This 
parameter exploration showed a number of relationships between effects and characteristics 
which can be explained by the mechanisms at play in the crypt. Lag between initial mutation 
events and flat mucosal invasion was affected by stem cell quiescent time, with a shorter 
quiescent time leading to a shorter lag.  This relationship is as expected, and due to the fact 
that a shorter quiescent period gives a competitive advantage in the stem cell niche, 
reducing the time taken for monoclonal conversion to occur [29], and hence the time until 
mutated cells emerge from the crypt onto the flat mucosa.  Our model also predicts that 
stiffer cells have lower lag times, due to the fact that stiff cells are driven up the side of the 
crypt more quickly by the mitotic pressure which drives passive migration in the crypt. 
Spatial spread had no discernible relationship with stem cell quiescent time. This can be 
explained by the fact that quiescent time has very little effect on overall cell production rates 
as the majority of mitosis occurs in cells which do not undergo a quiescent phase.  Increased 
attachment force led to increasing spatial spread, as high attachment force provides a 
competitive advantage that allows mutated cells to invade the flat mucosa [29].  Reducing 
the cell stiffness also caused an increase in spread rate. This is due to the forces which 
cause anoikis being moderated by the lower stiffness of the mutated cells, which again, 
gives the mutated cells a competitive advantage in the crypt mouth and flat mucosa. 
Rate of spread also did not appear to be affected by quiescent time, again because stem cell 
quiescent time has negligible effect on cell production rates in the crypt.  Low cell stiffness 
combined with high attachment force gave rise to the largest spread rate, and is driven by 
the same mechanisms.  There was, however, a secondary maximum in spread rate which 
corresponded to low attachment force and high cell stiffness. The mechanism which causes 
this is unknown, but may be related to the phenomenon that, as the number of cells required 
to achieve a given amount of overall spread is quadratic in the distance of spread so the 
initial expansion is rapid and falls off with distance. 
No parameter combination explored in Cell Experiment 2 led to crypt invasion, suggesting 
that, in mechanical terms, such events are extremely unlikely with biologically plausible 
parameters. In particular, the upwards pressure created by the passive migration of cells 
arising from stem cells’ mitoses in neighbouring crypts, and in lieu of chemoattractant 
signalling mechanisms actively attracting cells to enter these crypts, cells tend to migrate 
laterally on the flat mucosa. An implication of this model is that the “top down” hypothesis of 
field spread [11] may not be the primary mechanism prevalent during colon cancerisation.   
It was, however, discovered through a wider parameter exploration that greater than normal 
cell stiffness occasionally gave rise to crypt invasion.  This is unlikely to happen 
mechanically as cancerous cells are generally understood to be less stiff than wildtype [3]. 
This is a function of the switch from keratin to vimentin as primary component of 
intermediate filaments [35, 36]; our group have shown alterations in keratin-vimentin ratio in 
the colorectal mucosa in cancer-predisposing colitis [37] and around pre-malignant 
colorectal lesions [33]. However, it is possible that a signalling mechanism could potentially 
create a similar effect.  It is known that EphB signalling mediates cell-cell adhesion forces in 
order to create a sorting mechanism within the crypt [38], and a disruption of this mechanism 
could potentially create an advantage for mutated cells very similar to that seen by 
increasing cell stiffness beyond normal levels.  This would be an attractive target for future 
modelling efforts, as it is relatively straightforward to incorporate such a signalling 
mechanism into the current model. In addition, should evidence for a signalling mechanism 
actively attracting mutated cells to actively invade wildtype crypts arise, it is possible that 
inclusion in our model could give rise to predictions of top-down invasion. Research in this 
area remains relatively novel and piecemeal in the cancer area [39], but as evidence 
consolidates, this feature will be included in our model. 
Crypt Experiment 1 predicted a two-phase field growing from a single mutated crypt.  The 
first phase was a fringe of invaded flat mucosa, which initially expanded more quickly than 
the second phase, a core of fully mutated crypts.  The invaded mucosa eventually created a 
fringe ten crypts wide, before contracting to a narrow zone around the fully mutated region.  
This later contraction is most likely a geometrical effect, as the field expands the area 
required to grow the mucosal field grows as the square of the radius of the field but the 
number of mutated cells being created to invade that area only grows linearly with the radius 
of the fully mutated field.  This acts as a brake on the expansion of the mucosal field. 
This experiment appears to be the first time that a growing field has been modelled at this 
scale and over an extended period of time.  The total number of mutated crypts was 
approximately 41,000 which is in good agreement with the sizes of fields reported in-vivo in 
the literature [1]. At the end of our simulation of field expansion, the field remained in 
exponential growth after the equivalent of two decades of biological time, achieving a virtual 
diameter of around 40mm, which is a scale that would fall within the clinically observable 
range. This field size is broadly in agreement with previous estimates [1], however if 
unchecked the field would presumably continue to expand. There are a number of limitations 
of this model: the reference data for achieved field size are from ulcerative colitis rather than 
sporadic adenoma; the parameterisation of crypt fission rate is a best estimate from a single 
study of an elusive biological process, and the data acquired in mice. Future in silico studies 
might undertake parameter explorations at the upper scale to establish the effect of small 
changes in crypt fission rates on field growth, and the relative contributions of fission and 
Apc- cell invasion to overall field size. For instance, the values for crypt fission or death that 
give rise to clonal patches consistent with studies of X-inactivation [40] could be explored. 
Further studies in vivo may yield improved parameters for these processes allowing model 
refinement. Notwithstanding these limitations, the timelines from risk exposure to modest 
size field seem in accord with some epidemiological data [41] which suggest the exposure-
presentation window is in the decades timeframe. 
There is potential for further work to be done both in-vivo and in-silico to refine and validate 
the model to produce more detailed and accurate field spread predictions, which could 
potentially have clinical or prognostic uses. As the model can simulate clinically-relevant 
spatial scales, over a two-decade time span in only 12 hours of computational time, there is 
great scope for doing extensive studies such as simulating populations and cohorts to 
examine statistical outcomes of changes between groups, for example under different 
treatment regimes or long-term lifestyle nutrition interventions which would be prohibitively 
time-consuming to study in-vivo. Extending our 40000 crypt model to represent a truly organ 
scale is underway; this 4 million crypt model is being assessed for potential to explore the 
basis of polyclonal adenoma formation.  
Further possibilities include the use of the model to explore the concept of interactions of 
clones arising from subsequent mutations within an advancing field or entirely independent 
primary mutations arising from different crypts. Previous simulations carried out by Sottoriva 
et al using a cellular automata-based model capturing the probabilities of the fission or 
extinction of individual glands according to their mutation status have produced results 
suggesting that the earliest mutations are dominant within adenomas,and shown to be in 
agreement with experimental data [20].  Our approach, capturing phenotypic behaviours on 
the cellular scale, will allow exploration of the role of a diverse range of intra- and inter-crypt 
behaviour on field expansion and clonal interaction. 
Conclusions 
This study has used two agent based models and in vivo data to investigate the spread of 
pre-cancerous fields in the colonic epithelium.  The key findings are: 
• The cell level model predicts that mutated cells will spread through the flat mucosa 
above wildtype crypts, but that invasion of neighbouring crypts will not occur.  In vivo 
biopsy data suggests that this is indeed the case. 
• The crypt level model produces predictions in line with those of the cell level model, 
but is efficient enough to be run at clinically-relevant scales for multiple decades of 
biological time. 
Our work has generated predictions leading to further questions regarding the nature of field 
spread in the human colon, some of which may be targets for future in vivo or in vitro (e.g. 
using organoids). However, the ability to run computational simulations of the colon on time 
and length scales associated with in vivo cancer development opens up future possibilities 
for clinically relevant in silico exploration.  
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Figure 1 Multicrypt Model Development A: Visualisation of the cell scale model showing 
an array of 5x5 crypts. B: Visualisation of the crypt scale model output showing 
approximately 40,000 crypts.  Ci: The crypt cycle of wild-type crypts in the crypt scale model.  
In this example the crypt would fission once and die at the end of the example timespan, ii: 
The crypt cycle of a mutated crypt, in this example the crypt would fission ten times and 
never die.  D: Overlap resolution in the crypt scale model showing the various parameters 
referenced in Eq1 
 
Figure 2 Invasion of the Flat Mucosa.  A: Visualisation of the cell scale model showing 
mutated cells (green) from the central crypt invading the flat mucosa above neighbouring 
crypts (red), note that no mutated cells are present within the neighbour crypts themselves.  
B Alterations in keratin 18 (a biomarker of Apc loss) in the crypt and flat mucosa. (i) 
immunohistological staining for keratin 18 in crypt and flat mucosa showing examples of 
weak and strong staining at each location; (ii) comparison of keratin 18 staining in the crypts 
from patients without lesion adenoma (N)  or patients with a lesion (CO and MS samples 
from same patients, CO from adjacent to lesion, MS from distant to the lesion); (iii) the same 
samples’ scores at flat mucosa 
 
Figure 3 Mucosal Invasion Sensitivity Analysis.  A: A plot of spread distance against time for 
a typical simulation showing the three characteristic features measured in the parameter 
sweep experiment, specifically lag, spread rate, and overall spread distance.  B: Three 
dimensional plot showing the effect of quiescent time reduction, attachment force increase 
and cell stiffness reduction on the lag time before field spread onset.  C: Three dimensional 
plot of overall spread resistance plotted by the three mutation effects.  D: Plots of the effect 
of quiescent time reduction, attachment force increase, and cell stiffness on the rate of field 




Figure 4 A A visualisation of the crypt scale model after modification for validation against 
the cell scale model.  Yellow crypts are wild-type, red are mutated, and green are wild-type 
with mutated flat mucosa. B Plot of spread against time for the 6x6 cell scale model and the 













Figure 5 Crypt Scale Simulation Results.  A: Visualisation of the full sized crypt scale 
model after a single mutation event showing the growing fields of mutated crypts (red) and 
invaded mucosa (green).  B: A plot of spread distance against time for the experiment 
visualised in A, showing that both fields grow exponentially, with the mucosal field (green) 
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